Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleBrief Communication

68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use

Ata Ur Rehman Maaz, Jim O’Doherty and Mehdi Djekidel
Journal of Nuclear Medicine Technology September 2021, 49 (3) 265-268; DOI: https://doi.org/10.2967/jnmt.120.258939
Ata Ur Rehman Maaz
1Division of Hematology Oncology, Department of Pediatrics, Sidra Medicine, Doha, Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim O’Doherty
2Siemens Healthineers, Charleston, South Carolina; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdi Djekidel
3Division of Nuclear Medicine and Molecular Imaging, Department of Diagnostic Imaging, Sidra Medicine, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 49 no. 3 265-268
DOI 
https://doi.org/10.2967/jnmt.120.258939
PubMed 
33820858

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication October 20, 2020
  • Accepted for publication February 16, 2021
  • Published online September 3, 2021.

Article Versions

  • previous version (April 5, 2021 - 05:52).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Ata Ur Rehman Maaz1,
  2. Jim O’Doherty2 and
  3. Mehdi Djekidel3
  1. 1Division of Hematology Oncology, Department of Pediatrics, Sidra Medicine, Doha, Qatar;
  2. 2Siemens Healthineers, Charleston, South Carolina; and
  3. 3Division of Nuclear Medicine and Molecular Imaging, Department of Diagnostic Imaging, Sidra Medicine, Doha, Qatar
  1. For correspondence or reprints, contact Mehdi Djekidel (mdjekidel{at}sidra.org).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations
    Stephan D. Voss
    Pediatric Radiology 2023 53 7
  • 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
    Rahaf AlSadi, Ata Ur Rehman Maaz, Othmane Bouhali, Mehdi Djekidel
    Journal of Nuclear Medicine Technology 2023 51 2
  • A Practical Guide for Pediatric Nuclear Medicine
    Helen Nadel, Barry Shulkin, Zvi Bar-Sever, Francesco Giammarile
    2023
  • A unique presentation of neuroblastoma in Turner syndrome: A case report
    Sophie Jessop, Jill Lipsett, Manika Pal, Bridgid Connolly
    Pediatric Blood & Cancer 2022 69 4
  • Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature
    Philip Deslarzes, Reza Djafarrian, Maurice Matter, Stefano La Rosa, Carole Gengler, Maja Beck-Popovic, Tobias Zingg
    Frontiers in Pediatrics 2022 10
  • Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
    Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, Abdugani Musayev, Syrsulu Myrzagulova, Deepika Sharma, Nipun Padha, Manju Saini, Hardeep Singh Tuli, Tejveer Singh
    Molecular Neurobiology 2025 62 5
  • Imaging Recommendations for Theranostic PET-CT in Oncology
    Rahul V. Parghane, Abhishek Mahajan, Nivedita Chakrabarty, Sandip Basu
    Indian Journal of Medical and Paediatric Oncology 2023 44 03
  • Molecular Imaging and Therapy
    Jaykanth Amalachandran, Amol Takalkar, Thangalakshmi Sivathapandi, Lance T. Hall
    2023
  • Paraganglioma in Pregnancy with Recurrent Pregnancy Loss
    Wee Mee Cheng, Zanariah Hussein
    Journal of the ASEAN Federation of Endocrine Societies 2025
  • Pineal Gland Activity in Advanced-Stage Pediatric Neuroblastoma Patients on 68Ga-DOTATATE PET/CT
    Emine Goknur Isik, Dilara Denizmen, Dilşad Fırat Arslan, Duygu Has Simsek, Zeynep Gözde Özkan
    Clinical Nuclear Medicine 2025 50 4

Article usage

Article usage: April 2021 to April 2025

AbstractFullPdf
Apr 2021392010
May 202121507
Jun 2021151011
Jul 2021152012
Aug 2021174014
Sep 2021314711
Oct 20213052628
Nov 20212601420
Dec 202120423
Jan 20222521252
Feb 20221641022
Mar 20222051014
Apr 2022136116
May 2022182640
Jun 2022171743
Jul 2022124315
Aug 2022137529
Sep 2022376235
Oct 2022316451
Nov 2022195457
Dec 2022113328
Jan 2023175434
Feb 2023354435
Mar 2023405445
Apr 2023265335
May 2023256363
Jun 2023307735
Jul 2023217245
Aug 20232714147
Sep 2023188241
Oct 2023259047
Nov 2023188444
Dec 202387239
Jan 20241310337
Feb 20241710448
Mar 20241075105
Apr 2024157538
May 20241212956
Jun 20242210035
Jul 2024259339
Aug 20241911340
Sep 20243010755
Oct 20241511341
Nov 20241811947
Dec 202438634
Jan 20251510956
Feb 20251917646
Mar 20251615966
Apr 20251714560
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 49 (3)
Journal of Nuclear Medicine Technology
Vol. 49, Issue 3
September 1, 2021
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use
Ata Ur Rehman Maaz, Jim O’Doherty, Mehdi Djekidel
Journal of Nuclear Medicine Technology Sep 2021, 49 (3) 265-268; DOI: 10.2967/jnmt.120.258939

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-DOTATATE PET/CT for Neuroblastoma Staging: Utility for Clinical Use
Ata Ur Rehman Maaz, Jim O’Doherty, Mehdi Djekidel
Journal of Nuclear Medicine Technology Sep 2021, 49 (3) 265-268; DOI: 10.2967/jnmt.120.258939
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
  • 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
  • Google Scholar

More in this TOC Section

  • Patient Motion During Cardiac PET Imaging
  • Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
  • Fitness for Purpose of Text-to-Image Generative Artificial Intelligence Image Creation in Medical Imaging
Show more Brief Communication

Similar Articles

Keywords

  • neuroblastoma imaging
  • MIBG
  • 68Ga-DOTATATE
  • COVID-19
SNMMI

© 2025 SNMMI

Powered by HighWire